Literature DB >> 2987934

Overproduction of the protein product of a nonselected foreign gene carried by an adenovirus vector.

M Yamada, J A Lewis, T Grodzicker.   

Abstract

We have constructed a recombinant adenovirus that carries the herpes simplex virus type I gene for thymidine kinase (EC 2.7.1.21) and expresses thymidine kinase under control of adenovirus major late promoter. A DNA fragment carrying thymidine kinase coding sequences but lacking the thymidine kinase promoter was sandwiched between a piece of adenoviral DNA and simian virus 40 early DNA on a plasmid. The aligned fragment was then inserted into the adenoviral genome, replacing internal adenoviral DNA. Hybrid viruses carrying the thymidine kinase gene were obtained by selecting for viruses that express simian virus 40 tumor antigen (T antigen) in monkey cells. The thymidine kinase gene was positioned in the third segment of the adenovirus tripartite leader downstream from the major late promoter by in vivo DNA recombination between the duplicated adenoviral sequences present in the plasmid insert and the viral vector. Levels of thymidine kinase activity in human or monkey cells infected with this hybrid virus were several times higher than in cells infected with herpes simplex virus. Infected cells produced thymidine kinase protein at very high levels, similar to those found for adenovirus late major capsid proteins. The thymidine kinase protein represented 10% of the newly synthesized protein in late infected cells and accumulated to represent 1% of total cell protein under optimal conditions. This vector system offers a procedure by which a variety of gene products that are biologically active and properly modified can be produced at high levels in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2987934      PMCID: PMC397826          DOI: 10.1073/pnas.82.11.3567

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  ENHANCEMENT OF ADENOVIRUS GROWTH IN AFRICAN GREEN MONKEY KIDNEY CELL CULTURES BY SV40.

Authors:  A S RABSON; G T O'CONOR; I K BEREZESKY; F J PAUL
Journal:  Proc Soc Exp Biol Med       Date:  1964-05

2.  Regulation of tumor antigen synthesis by simain virus 40 gene A.

Authors:  P Tegtmeyer; M Schwartz; J K Collins; K Rundell
Journal:  J Virol       Date:  1975-07       Impact factor: 5.103

3.  Biochemical studies on the herpes simplex virus-specified deoxypyrimidine kinase activity.

Authors:  A T Jamieson; J H Subak-Sharpe
Journal:  J Gen Virol       Date:  1974-09       Impact factor: 3.891

4.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

5.  A virus-specific thymidine kinase in BHK-21 cells infected with herpes simplex virus.

Authors:  H G Klemperer; G R Haynes; W I Shedden; D H Watson
Journal:  Virology       Date:  1967-01       Impact factor: 3.616

6.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

9.  Biochemical consequences of type 2 adenovirus and Simian virus 40 double infections of African green monkey kidney cells.

Authors:  M P Friedman; M J Lyons; H S Ginsberg
Journal:  J Virol       Date:  1970-05       Impact factor: 5.103

10.  Nucleotide sequence of the rightward operator of phage lambda.

Authors:  T Maniatis; A Jeffrey; D G Kleid
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

View more
  12 in total

1.  A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase.

Authors:  S Kochanek; P R Clemens; K Mitani; H H Chen; S Chan; C T Caskey
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

2.  Development of a helper-independent human adenovirus vector and its use in the transfer of the herpes simplex virus thymidine kinase gene.

Authors:  Y Haj-Ahmad; F L Graham
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

Review 3.  Biocatalysis made to order.

Authors:  G Tripathi
Journal:  Appl Biochem Biotechnol       Date:  1988-10       Impact factor: 2.926

Review 4.  Use of vaccinia virus to express biopharmaceutical products.

Authors:  D E Hruby; G Thomas
Journal:  Pharm Res       Date:  1987-04       Impact factor: 4.200

Review 5.  Adenovirus-mediated gene transfer into striated muscles.

Authors:  G Acsadi; B Massie; A Jani
Journal:  J Mol Med (Berl)       Date:  1995-04       Impact factor: 4.599

6.  Rescue, propagation, and partial purification of a helper virus-dependent adenovirus vector.

Authors:  K Mitani; F L Graham; C T Caskey; S Kochanek
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

7.  Human identification and sex determination of dental pulp, bone marrow and blood stains with a recombinant DNA probe.

Authors:  T Yokoi; Y Aoki; K Sagisaka
Journal:  Z Rechtsmed       Date:  1989

8.  A human Y-chromosome specific repeated DNA family (DYZ1) consists of a tandem array of pentanucleotides.

Authors:  Y Nakahori; K Mitani; M Yamada; Y Nakagome
Journal:  Nucleic Acids Res       Date:  1986-10-10       Impact factor: 16.971

9.  Lysine: Is it worth more?

Authors:  D Datta; A Bhinge; V Chandran
Journal:  Cytotechnology       Date:  2001-07       Impact factor: 2.058

10.  Stable gene transfer and tissue-specific expression of a human globin gene using adenoviral vectors.

Authors:  S Karlsson; K Van Doren; S G Schweiger; A W Nienhuis; Y Gluzman
Journal:  EMBO J       Date:  1986-09       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.